These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20805184)

  • 1. Treatment of COPD: the sooner the better?
    Decramer M; Cooper CB
    Thorax; 2010 Sep; 65(9):837-41. PubMed ID: 20805184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.
    Bridevaux PO; Gerbase MW; Probst-Hensch NM; Schindler C; Gaspoz JM; Rochat T
    Thorax; 2008 Sep; 63(9):768-74. PubMed ID: 18505800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. It's about time--directing our attention toward modifying the course of COPD.
    Cazzola M; Hanania NA; Jones PW; Mahler DA; Make B; Ohar J; Rennard S
    Respir Med; 2008 Jun; 102 Suppl 1():S37-48. PubMed ID: 18582796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions.
    Anzueto A
    Am J Med; 2006 Oct; 119(10 Suppl 1):46-53. PubMed ID: 16996899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inspiratory capacity and forced expiratory volume in the first second in exacerbation of chronic obstructive pulmonary disease.
    Yetkin O; Gunen H
    Clin Respir J; 2008 Jan; 2(1):36-40. PubMed ID: 20298302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
    Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB
    COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression.
    Wise RA
    Am J Med; 2006 Oct; 119(10 Suppl 1):4-11. PubMed ID: 16996894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The UPLIFT study: future perspectives].
    Rodríguez González-Moro JM; Lucero S; de Lucas Ramos P
    Arch Bronconeumol; 2008; 44 Suppl 2():39-48. PubMed ID: 19087842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD.
    Schermer T; Heijdra Y; Zadel S; van den Bemt L; Boonman-de Winter L; Dekhuijzen R; Smeele I
    Respir Med; 2007 Jun; 101(6):1355-62. PubMed ID: 17098407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease modification in chronic obstructive pulmonary disease.
    Anzueto A
    Clin Chest Med; 2007 Sep; 28(3):609-16,vii. PubMed ID: 17720047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment for lung cancer with COPD based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD).
    Iwasaki A; Shirakusa T; Enatsu S; Maekawa S; Yoshida Y; Yoshinaga Y
    Thorac Cardiovasc Surg; 2005 Jun; 53(3):162-7. PubMed ID: 15926096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
    Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
    Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New clinical parameters in chronic obstructive pulmonary disease].
    Izquierdo Alonso JL
    Arch Bronconeumol; 2008; 44 Suppl 2():4-10. PubMed ID: 19087838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection and impaired quality of life in COPD GOLD stage 0: a pilot study.
    Maleki-Yazdi MR; Lewczuk CK; Haddon JM; Choudry N; Ryan N
    COPD; 2007 Dec; 4(4):313-20. PubMed ID: 18027158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression and Chronic Obstructive Pulmonary Disease: Treatment Trials.
    Borson S; Claypoole K; McDonald GJ
    Semin Clin Neuropsychiatry; 1998 Apr; 3(2):115-130. PubMed ID: 10085198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathomechanisms in chronic obstructive pulmonary disease (COPD)].
    Glaab T; Hohlfeld JM; Jörres RA; Krug N; Welte T
    Med Klin (Munich); 2006 Dec; 101(12):951-6. PubMed ID: 17171318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of inhaled corticosteroids for chronic obstructive pulmonary disease according to disease severity.
    Sin DD; Golmohammadi K; Jacobs P
    Am J Med; 2004 Mar; 116(5):325-31. PubMed ID: 14984818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence.
    Young RP; Hopkins R; Eaton TE
    Postgrad Med J; 2009 Aug; 85(1006):414-21. PubMed ID: 19633007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.